Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 3 of 180 results
Sort by: relevance publication year
Showing results for ISSN matching 1179-2728

Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy

JOURNAL ARTICLE published January 2015 in Lung Cancer: Targets and Therapy

Authors: Baofa Yu | Yuanfei Lu | Feng Gao | Peng Jing | Wei Han | Peichang Zhang | Guoliang Liu | Ning Ru | Guanghui Cui | Xinhai Xu | Chenglin Sun | Changjiang Guan | Yebing Che | Yingli Wu | Zhenlu Ma | Qiang Fu | Jian Liu | Huanyou Wang

https://doi.org/10.2147/lctt.s70679 Actions

ALESIA 5-Year Update: Alectinib at 600 mg Twice Daily Gives Lorlatinib a Run for Its Money in Asia

JOURNAL ARTICLE published July 2023 in Lung Cancer: Targets and Therapy

Authors: Alexandria TM Lee | Saihong Ignatius Ou

https://doi.org/10.2147/lctt.s419395 Actions

Emerging treatment options in the management of non-small cell lung cancer

JOURNAL ARTICLE published June 2011 in Lung Cancer: Targets and Therapy

Authors: Pier Luigi Filosso

https://doi.org/10.2147/lctt.s8618 Actions

Practical management of NSCLC patients with long-term bevacizumab treatment: a report of four cases

JOURNAL ARTICLE published October 2013 in Lung Cancer: Targets and Therapy

Authors: Daniel Dresden | Judith Herder | Joachim Aerts

https://doi.org/10.2147/lctt.s45309 Actions

Trajectory of chemotherapy for patients with EGFR wild-type advanced pulmonary adenocarcinoma: a single-institution retrospective study

JOURNAL ARTICLE published February 2017 in Lung Cancer: Targets and Therapy

Authors: Seigo Minami | Yoshitaka Ogata | Shouichi Ihara | Suguru Yamamoto | Kiyoshi Komuta

https://doi.org/10.2147/lctt.s124301 Actions

A pilot study of a metronomic chemotherapy regimen with weekly low-dose docetaxel for previously treated non-small cell lung cancer

JOURNAL ARTICLE published May 2012 in Lung Cancer: Targets and Therapy

Authors: Toshiki Shimizu

https://doi.org/10.2147/lctt.s30937 Actions

Deconstructing ADAURA. It is Not Yet Time to Forgo Platinum-based Adjuvant Chemotherapy in Resected Early Stage (IB-IIIA) EGFR-mutant NSCLC

JOURNAL ARTICLE published May 2022 in Lung Cancer: Targets and Therapy

Authors: Danielle Brazel | Misako Nagasaka

https://doi.org/10.2147/lctt.s346922 Actions

Modern management of malignant pleural mesothelioma

JOURNAL ARTICLE published May 2016 in Lung Cancer: Targets and Therapy

Authors: Jonathan Dowell | Shivani patel

https://doi.org/10.2147/lctt.s83338 Actions

Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges

JOURNAL ARTICLE published May 2021 in Lung Cancer: Targets and Therapy

Authors: Toshio Fujino | Kenichi Suda | Tetsuya Mitsudomi

https://doi.org/10.2147/lctt.s269307 Actions

<p>Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers</p>

JOURNAL ARTICLE published July 2019 in Lung Cancer: Targets and Therapy

Authors: Jan A. Stratmann | Martin Sebastian

https://doi.org/10.2147/lctt.s177618 Actions

Psychosocial challenges for patients with advanced lung cancer: interventions to improve well-being

JOURNAL ARTICLE published July 2017 in Lung Cancer: Targets and Therapy

Authors: Rebecca H Lehto

https://doi.org/10.2147/lctt.s120215 Actions

Deconstructing ADAURA: It is Time to Forgo Adjuvant Platinum-Based Chemotherapy in Resected IB-IIIA EGFR+ NSCLC (Except with RB Alterations?) When Adopting Adjuvant Osimertinib

JOURNAL ARTICLE published April 2022 in Lung Cancer: Targets and Therapy

Authors: Shannon S Zhang | Sai-Hong Ignatius Ou

https://doi.org/10.2147/lctt.s358902 Actions

EGFR mutations in patients with lung adenocarcinoma in southwest China: are G719S/A and L861Q more likely detected in tumors derived from smokers?

JOURNAL ARTICLE published July 2013 in Lung Cancer: Targets and Therapy

https://doi.org/10.2147/lctt.s44825 Actions

Genome-wide gene expression analysis of chemoresistant pulmonary carcinoid cells

JOURNAL ARTICLE published September 2010 in Lung Cancer: Targets and Therapy

Authors: Gerhard Hamilton

https://doi.org/10.2147/lctt.s12874 Actions

Clinical staging of malignant pleural mesothelioma: current perspectives

JOURNAL ARTICLE published August 2017 in Lung Cancer: Targets and Therapy

Authors: Maria Bonomi | Costantino De Filippis | Egesta Lopci | Letizia Gianoncelli | Giovanna Rizzardi | Eleonora Cerchiaro | Luigi Bortolotti | Alessandro Zanello | Giovanni Ceresoli

https://doi.org/10.2147/lctt.s102113 Actions

Profile of rociletinib and its potential in the treatment of non-small-cell lung cancer

JOURNAL ARTICLE published July 2016 in Lung Cancer: Targets and Therapy

Authors: Samuel Klempner | Phu Tran

https://doi.org/10.2147/lctt.s94337 Actions

Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives

JOURNAL ARTICLE published July 2017 in Lung Cancer: Targets and Therapy

Authors: Giulio Rossi | Genny Jocollé | Antonia Conti | Marcello Tiseo | Federica Zito Marino | Giovanni Donati | Renato Franco | Francesca Bono | Francesca Barbisan | Francesco Facchinetti

https://doi.org/10.2147/lctt.s120172 Actions

<p>The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer</p>

JOURNAL ARTICLE published January 2020 in Lung Cancer: Targets and Therapy

Authors: Yuen Yee Cheng | Emma M Rath | Anthony Linton | Man Lee Yuen | Ken Takahashi | Kenneth Lee

https://doi.org/10.2147/lctt.s186843 Actions

Targeting AXL in NSCLC

JOURNAL ARTICLE published August 2021 in Lung Cancer: Targets and Therapy

Authors: Aubhishek Zaman | Trever G Bivona

https://doi.org/10.2147/lctt.s305484 Actions

Efficacy and safety of erlotinib in the treatment of metastatic non-small-cell lung cancer

JOURNAL ARTICLE published December 2010 in Lung Cancer: Targets and Therapy

Authors: Serena Ricciardi

https://doi.org/10.2147/lctt.s10167 Actions
Feedback: support@crossref.org